FDA Approves New Nonprescription Eye Drop Brytly for Redness Relief

The U.S. FDA has approved Brytly (apraclonidine ophthalmic solution, 0.125%) as a new nonprescription eye drop. This marks the first over-the-counter eye drop containing apraclonidine, providing consumers with an expanded accessible option for relieving eye redness caused by minor irritations.